PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis.
Journal of International Medical Research（2023）
摘要
Saroglizatar was the most effective drug for improving NAFLD.INPLASY registration number: INPLASY202340066.
更多查看译文
关键词
fatty liver disease,metformin,ppar-alpha/gamma agonists,glucagon-like,non-alcoholic,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要